Tempus AI, Inc. (NASDAQ:TEM) is one of the 11 Best Performing IPOs in the Last 2 Years. The stock’s price target is raised following a strong second quarter and FDA approval for Tempus Pixel. Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook Copyright: argus456 / 123RF Stock Photo On August 08, 2025, Tempus AI, Inc. (NASDAQ:TEM) reported a second-quarter 2025 revenue of $314.6 million, an increase of 89.6%. The growth was attributed to a 115% increase in Genomics revenue driven by stron ...